Who is sponsoring NCT03920306?

NCT03920306 is sponsored by University of British Columbia.

What drugs are being tested in NCT03920306?

Interventions in NCT03920306: oral anti-acid treatment.

What condition does NCT03920306 study?

NCT03920306 studies Gastrocutaneous Fistula, Gastrostomy Complications.

Is NCT03920306 still recruiting?

NCT03920306 is currently status unknown. Last updated 21 January 2022.

Last reviewed 2022-01-21 · How we verify

NCT03920306: GCF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in Children

Status unknown Phase 4 Last updated 21 January 2022

What this trial tests

Phase 4 trial testing oral anti-acid treatment in Gastrocutaneous Fistula in 100 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
1 April 2023

1 October 2023

Quick facts

Lead sponsor	University of British Columbia
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	100
Start date	1 April 2019
Primary completion	1 April 2023
Estimated completion	1 October 2023
Sites	1 location across Canada

Drugs / interventions tested

oral anti-acid treatment — full drug profile →

Conditions studied

Gastrocutaneous Fistula — all drugs for Gastrocutaneous Fistula →
Gastrostomy Complications — all drugs for Gastrostomy Complications →

Sponsor

University of British Columbia

Who can join

Under 18, any sex, with Gastrocutaneous Fistula or Gastrostomy Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastrostomy tube placement is a common surgery, and involves placing a tube from the child's skin to the inside of their stomach, allowing an alternative route for nutrition and medication to patients who cannot tolerate oral intake. A common complication of gastrostomy tubes is the development of a persistent connection between the stomach and skin after their removal. This is called a gastrocutaneous fistula (GCF). Non-surgical options have shown some success in eliminating the need for surgery to close these fistulae. Their true efficacy is unknown however; this study evaluates a non-surgical intervention bundle in the prevention and treatment of GCFs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03920306 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 21 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920306.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing